Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Aya Shiba‐Ishii"'
Autor:
Fumiya Teruyama, Akihiro Kuno, Yoshihiko Murata, Tomoki Nakagawa, Aya Shiba‐Ishii, Shu Yuguchi, Masayuki Noguchi
Publikováno v:
Pathology International. 72:457-463
Autor:
Masayuki Noguchi, Yukio Sato, Yukinori Kozuma, Noriaki Sakamoto, Shingo Sakashita, Tomoki Nakagawa, Yunjung Kim, Takatsugu Hirokawa, Jeongmin Hong, Aya Shiba-Ishii
Table S2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97b12d09c175570daeb35e4fe487b7bc
https://doi.org/10.1158/1078-0432.22473911.v1
https://doi.org/10.1158/1078-0432.22473911.v1
Autor:
Masayuki Noguchi, Yukio Sato, Yukinori Kozuma, Noriaki Sakamoto, Shingo Sakashita, Tomoki Nakagawa, Yunjung Kim, Takatsugu Hirokawa, Jeongmin Hong, Aya Shiba-Ishii
Purpose:Aberrant overexpression of SFN (stratifin) plays an oncogenic role in lung adenocarcinoma. We have shown previously that SKP1, an adapter component of E3 ubiquitin ligase forming an SCF complex, is a unique SFN-binding protein in lung adenoca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45eaaeb7417cfca182aab4af4ecf52c5
https://doi.org/10.1158/1078-0432.c.6528632
https://doi.org/10.1158/1078-0432.c.6528632
Autor:
Masayuki Noguchi, Yukio Sato, Yukinori Kozuma, Noriaki Sakamoto, Shingo Sakashita, Tomoki Nakagawa, Yunjung Kim, Takatsugu Hirokawa, Jeongmin Hong, Aya Shiba-Ishii
Figure S1-7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6909e0d1e885920ecaa13aef70073a3d
https://doi.org/10.1158/1078-0432.22473920.v1
https://doi.org/10.1158/1078-0432.22473920.v1
Autor:
Masayuki Noguchi, Yukio Sato, Yukinori Kozuma, Noriaki Sakamoto, Shingo Sakashita, Tomoki Nakagawa, Yunjung Kim, Takatsugu Hirokawa, Jeongmin Hong, Aya Shiba-Ishii
Supplementary material and method and figure legends.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9914f6b24a05dacc6e51b9c8578a4c7a
https://doi.org/10.1158/1078-0432.22473917
https://doi.org/10.1158/1078-0432.22473917
Publikováno v:
Cancer Science
Ovarian carcinoma immunoreactive antigen domain 2 (OCIAD2) has been reported to show significantly higher expression in invasive lung adenocarcinoma than in lung adenocarcinoma in situ, and its abnormal expression is associated with poorer prognosis
Autor:
Aya Shiba-Ishii
Publikováno v:
Pathology International. 71:655-665
Lung cancer is the most common cause of global cancer-related mortality, and the main histological type is adenocarcinoma, accounting for 50% of non-small cell lung cancer. In 2015, the World Health Organization (WHO) histological classification defi
Autor:
Aaron N. Hata, Jennifer L Peterson, Scott L. Weinrich, Satoshi Yoda, Jessica J. Lin, Adam Acker, Aya Shiba-Ishii, Ibiayi Dagogo-Jack, Lesli A. Kiedrowski, Justin F. Gainor, Kristin Dionne, Michele McTigue, Andrew Do, Makeba A Walcott, Mari Mino-Kenudson, Jaimie L. Barth, Ted William Johnson, Beow Y. Yeap, Ping Wei, Linh Nguyen-Phuong, Theodore R. Johnson
The treatment approach to advanced, ALK-positive non-small cell lung cancer (NSCLC) utilizing sequential ALK tyrosine kinase inhibitors (TKIs) represents a paradigm of precision oncology. Lorlatinib is currently the most advanced, potent and selectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a276b417464b334652691d18f8ae4c0
https://doi.org/10.1101/2021.07.16.452681
https://doi.org/10.1101/2021.07.16.452681
Autor:
Aya Shiba-Ishii, Ted W. Johnson, Ibiayi Dagogo-Jack, Mari Mino-Kenudson, Theodore R. Johnson, Ping Wei, Scott L. Weinrich, Michele A. McTigue, Makeba A. Walcott, Linh Nguyen-Phuong, Kristin Dionne, Adam Acker, Lesli A. Kiedrowski, Andrew Do, Jennifer L. Peterson, Jaimie L. Barth, Beow Y. Yeap, Justin F. Gainor, Jessica J. Lin, Satoshi Yoda, Aaron N. Hata
Publikováno v:
Nat Cancer
Lorlatinib is currently the most advanced, potent and selective anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor for the treatment of ALK-positive non-small cell lung cancer in the clinic; however, diverse compound ALK mutations driving the
Autor:
Masafumi Muratani, Karina Ramirez, Tatsuo Iijima, Noriaki Sakamoto, Yunjung Kim, Masayuki Noguchi, Aya Shiba-Ishii
Publikováno v:
Cancer Science
The landscape of genetic alterations in disease models such as transgenic mice or mice with carcinogen‐induced tumors has provided a huge amount of information that has shed light on the process of tumorigenesis in human non‐small‐cell lung can